Radar > 258358

Pangaea Oncology sings agreement with Merck Group, allowing Germany-based multinational to use its services

Pangaea Oncology firma un acuerdo con Merck Group por el que ofrecerá sus servicios a la multinacional alemana

Intel ID : 258358

Relevant Documents


Intel ID 258358
Value ND
Native Currency Euro (EUR)
Financial Data - Pangaea Oncology
(31 Dec 2022)
Revenue: EUR 7,09m
Date
Country
Region
Continent
Geography
Subsector (Old TTR Sectors)
Type
Intel Grade
Source
Tags

Bidder

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Bidder

Name
verified
Subsector (Old TTR Sectors)
Technology and Telecoms / Biotechnology (Primary)
Services and Distribution / Healthcare, Hygiene, Medical Aesthetics and Cosmetics
Primary Sector (TTRSC)
30.01.99 Other Biotechnology & Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
15.06.01 Colleges & Universities
15 Consumer Products & Services / 15.06 Education & Training Services

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.